FDA prohibits the drug after 53 years of

The Food and Drug Administration has directed that propoxyphene, a medication for pain, be withdrawn from the market and is no longer sold in this country. The FDA cited studies showing propoxyphene increases the risk of serious heart problems. An opiate with addictive potential, prescribed very widely. In 2009, recipes 17.5 million were written Propoxyphene, sold under its brand name and generic versions for.

Propoxyphene has been in the spotlight of drug regulators for years, both by concerns about their safety and effectiveness. The difference between a safe dose and a fatal overdose is small. British regulators prohibiting its sale in 2005, citing reports of a number unexpectedly high deaths associated with its use. The deaths occurred in Florida, where medical examiners do very thorough toxicological studies.Another study to examine deaths related to drug in eight States, including Florida, found that more deaths associated with propoxyphene than with other, more powerful analgesicos.En 2009 EU banned its sale and use in the EU countries.

Another study showed dangerous electric heart activity changes between individuals without heart disease who took propoxyphene. This, as well as other studies were enough to convince the FDA this year that the risks of maintaining this drug on the market outweighed the potential benefits.

Value of propoxyphene as a pain management drugs has been questioned by some time.Compared the effectiveness of acetaminophen, the active ingredient in Tylenol acetaminophen and Propoxyphene, no difference in pain relief can see the addition of propoxyphene.

The FDA approved propoxyphene in 1957, and the drug had won billions of dollars in profits to its manufacturer original.La company sold their rights to the name in 2005 and is no longer involved in the manufacture or venta.La majority of propoxyphene is sold as a generic.Public citizen, a group of consumers, for a long time been concerned for the safety of propoxyphene and on its health research group has pressured quitarlo.El FDA Dr. Sidney Wolfe Health Research Group commended the decision to withdraw the drug and also expressed its concern that the FDA has left this and other dangerous drugs remain on the market too long.

People who use propoxyphene should talk with your doctor authorized on safe and effective alternative drugs for the treatment of pain.

Gayle Blatt is a lawyer who believes that equal protection under the law means aggressive representation for persons against irresponsible actions farmaceutica.En industry pharmaceutical litigation his years represent victims advocate pharmaceutical Gayle Blatt chooses to provide counsel to individuals rather than shares of class, personally allowing you to focus on the unique needs of each individual client.

Article source: http://EzineArticles.com/?expert=Gayle_Blatt